-
EP1025121
European procedure
Extract from the Register of European Patents
EP About this file: EP1025121
| EP1025121 - PEPTIDES CAPABLE OF INHIBITING THE INTERACTION BETWEEN PRESENILINS AND THE BETA-AMYLOID PEPTIDE OR ITS PRECURSOR [Right-click to bookmark this link] | |||
| Former [2000/32] | PEPTIDES CAPABLE OF INHIBITING THE INTERACTION BETWEEN PRESENILINS AND THE $g(b)-AMYLOID PEPTIDE OR ITS PRECURSOR | ||
| [2010/49] | Status | No opposition filed within time limit Status updated on 29.06.2012 Database last updated on 15.07.2024 | Most recent event Tooltip | 29.06.2012 | No opposition filed within time limit | published on 01.08.2012 [2012/31] | Applicant(s) | For all designated states Aventis Pharma S.A. 20, avenue Raymond Aron 92160 Antony / FR | [2000/32] | Inventor(s) | 01 /
CZECH, Christian 4, Cité de l'Alma F-75007 Paris / FR | 02 /
MERCKEN, Luc 18 bis, rue Jules Joffrin F-94100 Saint Maur / FR | 03 /
PRADIER, Laurent 23, avenue Cambacérès F-91370 Verrières / FR | 04 /
REBOUL-BECQUART, Soline 10, avenue de Verdun F-92120 Montrouge / FR | [2000/32] | Representative(s) | Bouvet, Philippe Aventis Pharma S.A. Direction des Brevets Tri LEO/144 20 Avenue Raymond Aron 92165 Antony Cedex / FR | [N/P] |
| Former [2000/32] | Bouvet, Philippe Rhône-Poulenc Rorer S.A. 20, Avenue Raymond Aron 92160 Antony / FR | Application number, filing date | 98951547.3 | 23.10.1998 | [2000/32] | WO1998FR02278 | Priority number, date | FR19970013384 | 24.10.1997 Original published format: FR 9713384 | US19980095671P | 07.08.1998 Original published format: US 95671 P | [2000/32] | Filing language | FR | Procedural language | FR | Publication | Type: | A1 Application with search report | No.: | WO9921886 | Date: | 06.05.1999 | Language: | FR | [1999/18] | Type: | A1 Application with search report | No.: | EP1025121 | Date: | 09.08.2000 | Language: | FR | The application published by WIPO in one of the EPO official languages on 06.05.1999 takes the place of the publication of the European patent application. | [2000/32] | Type: | B1 Patent specification | No.: | EP1025121 | Date: | 24.08.2011 | Language: | FR | [2011/34] | Search report(s) | International search report - published on: | EP | 06.05.1999 | Classification | IPC: | C07K14/47, C12N15/12, C12N5/10, C12N15/86, C07K16/18 | [2000/32] | CPC: |
G01N33/502 (EP);
C07K14/47 (KR);
A61P25/28 (EP);
C07K14/4711 (EP);
G01N33/5008 (EP);
G01N33/542 (EP);
G01N33/6896 (EP);
A61K38/00 (EP);
A61K48/00 (EP);
C07K2319/02 (EP);
C12N2799/021 (EP);
G01N2333/4709 (EP);
G01N2500/02 (EP)
(-)
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, NL, PT, SE [2000/32] | Extension states | SI | 25.04.2000 | Title | German: | PEPTIDE DIE DIE WECHSELWIRKUNG ZWISCHEN PRESENILINEN UND BETA-AMYLOIDPEPTID ODER SEINEM VORLÄUFER HEMMEN | [2011/08] | English: | PEPTIDES CAPABLE OF INHIBITING THE INTERACTION BETWEEN PRESENILINS AND THE BETA-AMYLOID PEPTIDE OR ITS PRECURSOR | [2010/49] | French: | PEPTIDES CAPABLES D'INHIBER L'INTERACTION ENTRE LES PRESENILINES ET LE PEPTIDE BETA-AMYLOIDE OU SON PRECURSEUR | [2010/49] |
| Former [2000/32] | PEPTIDE DIE DIE WECHSELWIRKUNG ZWISCHEN PRESENILINS UND BETA-AMYLOIDPEPTID ODER SEIN VORLÄUFER HEMMEN | ||
| Former [2000/32] | PEPTIDES CAPABLE OF INHIBITING THE INTERACTION BETWEEN PRESENILINS AND THE $g(b)-AMYLOID PEPTIDE OR ITS PRECURSOR | ||
| Former [2000/32] | PEPTIDES CAPABLES D'INHIBER L'INTERACTION ENTRE LES PRESENILINES ET LE PEPTIDE SS-AMYLOIDE OU SON PRECURSEUR | Entry into regional phase | 25.04.2000 | National basic fee paid | 25.04.2000 | Designation fee(s) paid | 25.04.2000 | Examination fee paid | Examination procedure | 12.05.1999 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 25.04.2000 | Examination requested [2000/32] | 04.04.2007 | Despatch of a communication from the examining division (Time limit: M06) | 15.10.2007 | Reply to a communication from the examining division | 02.06.2008 | Despatch of a communication from the examining division (Time limit: M04) | 23.07.2008 | Reply to a communication from the examining division | 22.07.2009 | Despatch of a communication from the examining division (Time limit: M02) | 14.09.2009 | Reply to a communication from the examining division | 29.10.2010 | Cancellation of oral proceeding that was planned for 26.11.2010 | 26.11.2010 | Date of oral proceedings (cancelled) | 08.02.2011 | Communication of intention to grant the patent | 31.05.2011 | Fee for grant paid | 31.05.2011 | Fee for publishing/printing paid | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 04.04.2007 | Opposition(s) | 25.05.2012 | No opposition filed within time limit [2012/31] | Fees paid | Renewal fee | 22.09.2000 | Renewal fee patent year 03 | 15.10.2001 | Renewal fee patent year 04 | 31.10.2002 | Renewal fee patent year 05 | 31.10.2003 | Renewal fee patent year 06 | 02.11.2004 | Renewal fee patent year 07 | 31.10.2005 | Renewal fee patent year 08 | 12.10.2006 | Renewal fee patent year 09 | 12.10.2007 | Renewal fee patent year 10 | 31.03.2008 | Renewal fee patent year 11 | 13.10.2009 | Renewal fee patent year 12 | 11.10.2010 | Renewal fee patent year 13 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO9213069 (IMPERIAL COLLEGE [GB]) [A] 1,8-10,16,20 * page 47 - page 48 *; | [A]WO9634099 (HSC RES DEV LP [CA], et al) [A] 1-7,11,12,16-19,21-51 * page 3, line 21 - page 10, line 17 * * page 11, line 2 - page 12, line 6 *; | [YA]WO9727296 (HSC RES DEV LP [CA], et al) [Y] 1 * page 56, line 10 - page 59, line 2 * [A] 11,12,20-22,36-38,42-51; | [DYAX] - XIA W ET AL, "Interaction between amyloid precursor protein and presenilins in mammalian cells: Implications for the pathogenesis of Alzheimer disease", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA., WASHINGTON US, (199707), vol. 94, pages 8208 - 8213, XP002067171 [DY] 1 * the whole document * [A] 2-10,16-22,24,25,33,38,40 [X] 23,44 DOI: http://dx.doi.org/10.1073/pnas.94.15.8208 | [A] - KIM S S ET AL, "Lack of interactions between amyloid precursor protein and hydrophilic domains of presenilin 1 and 2 using the yeast two hybrid system", JOURNAL OF MOLECULAR NEUROSCIENCE, TOTOWA US, (199708), vol. 9, no. 1, pages 49 - 54, XP002072945 [A] 1 * the whole document * | [DXA] - WEIDEMANN A ET AL., "Formation of stable complexes between two Alzheimer's disease gene products: Presenilin-2 and beta amyloid precursor protein", NATURE MEDICINE., NEW YORK US, (199703), vol. 3, no. 3, pages 328 - 332, XP002067172 [DX] 21,44 * the whole document * [A] 1,24,25,33 DOI: http://dx.doi.org/10.1038/nm0397-328 | [A] - WARAGAI M ET AL., "Presenilin 1 binds to amyloid precursor protein directly", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS., ORLANDO, FL US, (19971020), vol. 239, pages 480 - 482, XP002094076 [A] 1 * the whole document * DOI: http://dx.doi.org/10.1006/bbrc.1997.7488 | [PX] - WEIDEMANN A ET AL., "Modulation of APP metabolism by presenilin-2 derivatives", SOCIETY FOR NEOROSCIENCE ABSTRACTS, US, (19971025), vol. 23, no. 1-2, page 1118, XP002094077 [PX] 1-3,24,25,33 * voir abérégé no. 443.10 * | [T] - HAAS C ET AL., "A technical KO of amyloid-beta peptide", NATURE., LONDON GB, (19980122), vol. 391, pages 339 - 340, XP002094078 [T] 1 * the whole document * DOI: http://dx.doi.org/10.1038/34800 | [T] - THINAKARAN G ET AL, "Stable association of presenilin derivatives and absence of presenilin interactions with APP", NEUROBIOLOGY OF DISEASE, NEW YORK US, (1998), vol. 4, no. 6, pages 438 - 453, XP002072947 [T] 1 * the whole document * DOI: http://dx.doi.org/10.1006/nbdi.1998.0171 |